Angivent Tablet

About Angivent 35 mg Tablet

Angivent is a brand of Trimetazidine Dihydrochloride, a metabolic anti-ischaemic medicine used in adults as add-on therapy for stable angina pectoris. It comes as a 35 mg tablet from Square Pharmaceuticals PLC.

There are 13 brands of Trimetazidine Dihydrochloride listed in Bangladesh. The lowest listed price is Feelnor 20 mg Tablet at ৳ 3 per unit.

What is Angivent 35 mg Tablet?

Angivent 35 mg tablet contains Trimetazidine Dihydrochloride, which belongs to a group of other anti-anginal and anti-ischaemic drugs. It works as a metabolic agent: it shifts the heart's energy production towards glucose oxidation, which uses oxygen more efficiently. It is used in adults as add-on therapy for the symptomatic treatment of stable angina pectoris when first-line anti-anginal therapies do not control symptoms well enough or are not tolerated. It is not a curative treatment for angina attacks and is not an initial treatment for unstable angina or a treatment for myocardial infarction. The doctor decides the dose and course.

Uses of Angivent

Angivent is used in adults alongside other medicines for the symptomatic treatment of stable angina pectoris, when first-line anti-anginal therapies are not adequate or are not tolerated. It is add-on therapy, not a stand-alone treatment. It is not meant to relieve an angina attack, to treat unstable angina as an initial treatment, or to treat myocardial infarction. Ask the doctor whether it suits your condition.

How to use Angivent

The doctor decides the dose and how long you take Angivent. Swallow the tablet as your doctor or pharmacist instructs. The benefit of treatment is assessed after three months, and the medicine is stopped if there is no response. Do not change the dose or stop on your own. Tell your doctor about other medicines you take and any health conditions before starting.

Side effects of Angivent

Some people may notice dizziness, headache, abdominal pain, diarrhoea, indigestion, nausea, vomiting, rash, itching, hives or weakness. These are the common side effects reported with Trimetazidine. If any side effect troubles you or does not settle, contact your doctor or pharmacist. Do not decide on your own to stop or change the medicine; the doctor will advise what to do.

Safety and precautions

Angivent is not suitable for everyone. It is contraindicated in people with Parkinson's disease, parkinsonian symptoms, tremors or restless legs movement disorders, and in those with severe renal impairment. It is also contraindicated in anyone hypersensitive to the active substance or to any of the excipients. It is not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris, and it is not a treatment for myocardial infarction. There is no data on use in pregnancy, and it should not be used during breast-feeding. Tell your doctor if you are pregnant, planning pregnancy or breast-feeding, and ask a doctor first if you have kidney problems or movement symptoms. Keep it in a dry place away from light and heat and out of the reach of children.

Frequently asked questions

How should Angivent be taken?

The doctor decides the dose and the course of treatment. Follow the doctor's or pharmacist's instructions and do not change the dose or stop the medicine on your own. The benefit of treatment is assessed after three months, and it is stopped if there is no response.

What is Angivent used for and what kind of medicine is it?

Angivent contains Trimetazidine Dihydrochloride, a metabolic anti-ischaemic medicine grouped with other anti-anginal drugs. It is used in adults as add-on therapy for the symptomatic treatment of stable angina pectoris when first-line anti-anginal therapies do not control symptoms well enough or are not tolerated.

Which medicines may interact with Angivent?

No drug interaction has been reported so far, including with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidaemic agents or digitalis preparations. Still, tell your doctor or pharmacist about every medicine you take, including those bought without a prescription, so your treatment can be checked.

Who should not take Angivent?

It should not be taken by people with Parkinson's disease, parkinsonian symptoms, tremors or restless legs movement disorders, or with severe renal impairment. It is also contraindicated in anyone hypersensitive to the active substance or excipients. It should not be used during breast-feeding, and pregnancy should be avoided. Ask your doctor first.

Indications

Trimetazidine Dihydrochloride is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies.

Pharmacology

Trimetazidine Dihydrochloride is the first 3- keto acyl CoA thiolase inhibitor (KAT), a metabolic anti-ischemic agent with proven benefits for all coronary patients. Trimetazidine Dihydrochloride inhibits fatty acid pathway by inhibiting 3-keto acyl CoA thiolase enzyme and transfers oxygen to glucose pathway. Since glucose pathway is more efficient in producing energy, the same oxygen produces more energy and makes the heart more active. Moreover, the aerobic oxidation of glucose stops production of lactic acid, which prevents angina pectoris.

Dosage & Administration

The recommended dose of Trimetazidine is 35 mg twice daily or 20 mg tablet thrice daily during meals. The benefit of the treatment should be assessed after three months and Trimetazidine should be discontinued if there is no treatment response.

Interaction

No drug interaction so far has been reported. In particular, no interaction has been reported with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidemic agents or digitalis preparation.

Contraindications

Trimetazidine is contraindicated in patients who have hypersensitivity to the active substance or to any of the excipients. It is also is contraindicated in patients with Parkinson’s disease, parkinsonian symptoms, tremors, restless legs movement disorders, severe renal impairment.

Side Effects

Trimetazidine is safe and well tolerated. The Common side effects associated with Trimetazidine are dizziness, headache, abdominal pain, diarrhoea, dyspepsia, nausea, vomiting, rash, pruritus, urticaria and asthenia

Pregnancy & Lactation

There is no data on the use of Trimetazidine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure, it is preferable to avoid the use of Trimetazidine during pregnancy. It is unknown whether Trimetazidine is excreted in human milk. A risk to the newborns/infants cannot be excluded. Trimetazidine should not be used during breast-feeding.

Precautions & Warnings

Trimetazidine is not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris. It is also not a treatment for myocardial infarction.

Storage Conditions

Keep in a dry place away from light and heat. Keep out of the reach of children.

Alternative brands of Trimetazidine Dihydrochloride

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.